- 专利标题： ANTIBODIES TO MUCIN-16 AND METHODS OF USE THEREOF
-
申请号： US17292749申请日： 2019-11-14
-
公开(公告)号： US20210403597A1公开(公告)日： 2021-12-30
- 发明人: David SPRIGGS , Javier MORALES , Yoko NAKANO , Hong LIU
- 申请人： Memorial Sloan Kettering Cancer Center , Eureka Therapeutics, Inc.
- 申请人地址： US NY New York; US CA Emeryville
- 专利权人： Memorial Sloan Kettering Cancer Center,Eureka Therapeutics, Inc.
- 当前专利权人： Memorial Sloan Kettering Cancer Center,Eureka Therapeutics, Inc.
- 当前专利权人地址： US NY New York; US CA Emeryville
- 国际申请： PCT/US2019/061503 WO 20191114
- 主分类号： C07K16/30
- IPC分类号： C07K16/30 ; A61P35/00
摘要：
Provided herein are compositions, methods, and uses involving anti-Mucin-16 (MUC16) agents that immunospecifically bind an epitope of Mucin-16 (MUC16). Also provided herein are uses and methods for managing, treating, or preventing disorders, such as cancer and diseases associated with positive MUC16 expression.
信息查询
